Entegris Announces CEO Succession Plan
Bertrand Loy to Retire After 13 Years as President and CEO in August 2025; Will Continue to Serve as Executive Chair of the Entegris Board of Directors David Reeder... Read more.
Chewy CFO David Reeder to Depart Chewy, Company Reaffirms First Quarter Guidance
PLANTATION, Fla.–(BUSINESS WIRE)–Chewy, Inc. (NYSE: CHWY), a trusted destination for pet parents and partners everywhere, announced today that the Company’s... Read more.
IonQ to Present at The Economist Impact’s Commercialising Quantum Global 2025 Event
IonQ’s Dr. Dean Kassmann will discuss recent company advancements in quantum computing, networking and applications COLLEGE PARK, Md.–(BUSINESS WIRE)–IonQ... Read more.
Circle Pharma to Present Trials in Progress Poster on CID-078, a First-in-Class Cyclin A/B Inhibitor, at the ASCO 2025 Annual Meeting
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–#ASCO2025–Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics... Read more.
ADS-TEC Energy Reports Full Year 2024 Financial Results and Provides Business Update
NÜRTINGEN, Germany–(BUSINESS WIRE)–#battery—ADS-TEC Energy (NASDAQ: ADSE), a global leader in battery-based energy storage and fast-charging... Read more.
David Bailey and Bitcoin-Native Holding Company Nakamoto Announce Merger with KindlyMD® to Establish Bitcoin Treasury
Raises $510 Million PIPE and $200 Million in Convertible Notes Marking Largest Capital Raise to Launch a Bitcoin Treasury and the Largest PIPE for Any Public Crypto-Related... Read more.
Essential Utilities Reports Strong First Quarter 2025 Results, 2025 Guidance and Long-Term Targets Affirmed
Earnings per share of $1.03 for Q1 2025 vs. $0.97 for Q1 2024 2025 earnings per share guidance range of $2.07 to $2.11 affirmed Long-term targets also affirmed Invested... Read more.
D-Wave CEO Dr. Alan Baratz Discusses Company’s Technical and Commercial Momentum on Fox Business’ The Claman Countdown
PALO ALTO, Calif.–(BUSINESS WIRE)–D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing... Read more.
Dentalcorp Reports First Quarter 2025 Results
Robust revenue growth and continued margin expansion maintain track record of double digit growth in Adjusted EBITDA and Adjusted Free Cash Flow per Share First... Read more.
Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS)
Ad hoc announcement pursuant to Art. 53 LR ENIGMA-TRS 1 is an international, one-year, double-blind, placebo-controlled Phase III study in at least 600 patients;... Read more.